Lancet OncolJClub
Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission.
The Lancet Oncology · · Review
Casolino, Mateo + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Access to cancer genomics and precision oncology remains profoundly unequal across and within countries, leaving millions without guideline-indicated interventions annually.
- Why it matters: Addressing these disparities is crucial because they limit equitable cancer care and hinder the generation of comprehensive evidence needed for broad clinical benefit.
- What they did: The Commission analyzed the global landscape, identifying scientific, structural, and health-system challenges, and developed frameworks and tools to support effective, equitable, and sustainable integration.
- The result: Implementing these strategies can improve outcomes and strengthen health systems by scaling cancer genomics and precision oncology in a way that aligns with evidence, public value, and patient needs.
The findingWhy it mattersWhat they didThe result
- 10 cites